Upcoming Share Buybacks: Wipro, Aurobindo Pharma, and More
Share buybacks this month: Wipro, Aurobindo Pharma, 2 other stocks to watch out for
The Economic TimesImage: The Economic Times
Four companies, including Wipro, Aurobindo Pharma, Cyient, and Windlas Biotech, are set to announce share buybacks this month. Aurobindo Pharma's buyback is confirmed for April 17, with a repurchase price of ₹1,475 per share, while Wipro will consider its proposal on April 16.
- 01Wipro's board will consider a buyback on April 16.
- 02Aurobindo Pharma's buyback is set for April 17 at ₹1,475 per share.
- 03Windlas Biotech plans its first-ever buyback proposal on April 17.
- 04Cyient will discuss its buyback proposal on April 23.
- 05Recent tax changes affect promoters with a 12% surcharge on capital gains.
Advertisement
In-Article Ad
This month, four companies are poised to announce share buybacks, with Aurobindo Pharma leading the way. The company has approved a buyback worth ₹800 crore (approximately $96 million USD) at a price of ₹1,475 per share, a 10% premium over its previous closing price of ₹1,339.80 on the National Stock Exchange (NSE). Wipro will consider its buyback proposal alongside its financial results on April 16, marking its fifth buyback since its last in 2020. Windlas Biotech will also discuss its first-ever buyback on April 17, while Cyient's board will meet on April 23 to consider its own buyback proposal. Recent tax changes under the Finance Bill 2026 impose a 12% surcharge on capital gains from share buybacks, specifically affecting promoters, while non-promoter shareholders remain under normal provisions.
Advertisement
In-Article Ad
The share buybacks could boost stock prices and provide liquidity for shareholders, especially for those holding Aurobindo Pharma shares at the buyback price.
Advertisement
In-Article Ad
Reader Poll
Do you think share buybacks are beneficial for investors?
Connecting to poll...
More about Wipro

Addressing Workplace Conduct: Beyond Compliance to Culture
Business Standard • Apr 20, 2026

Key Developments in US-Iran Relations, Women's Quota Bill Defeated, and Q4 Financial Results
Ndtv • Apr 18, 2026
Wipro's ₹15,000 Crore Buyback Fails to Boost Investor Confidence Amid Earnings Miss
The Economic Times • Apr 18, 2026
Read the original article
Visit the source for the complete story.

